메뉴 건너뛰기




Volumn 182, Issue C, 2010, Pages 281-294

Somatostatin analogues: Treatment of pituitary and neuroendocrine tumors

Author keywords

Neuroendocrine tumors (NET); Octreotride; Pituitary tumors; Somatostatin; Somatostatin analogues

Indexed keywords

ANGIOPEPTIN; ANTINEOPLASTIC AGENT; CYCLOPEPTIDE; DRUG DERIVATIVE; OCTREOTIDE; SOMATOSTATIN;

EID: 77956639140     PISSN: 00796123     EISSN: 18757855     Source Type: Book Series    
DOI: 10.1016/S0079-6123(10)82012-6     Document Type: Chapter
Times cited : (32)

References (76)
  • 1
    • 11144357696 scopus 로고    scopus 로고
    • Pharmacokinetics of a new autogel formulation of the somatostatin analogue lanreotide after a single subcutaneous dose in healthy volunteers
    • Antonijoan, R. M., Barbanoj, M. J., Cordero, J. A., Peraire, C., Obach, R., Vallès, J., et al. (2004). Pharmacokinetics of a new autogel formulation of the somatostatin analogue lanreotide after a single subcutaneous dose in healthy volunteers. Journal of Pharmacy and Pharmacology, 56(4), 471-476.
    • (2004) Journal of Pharmacy and Pharmacology , vol.56 , Issue.4 , pp. 471-476
    • Antonijoan, R.M.1    Barbanoj, M.J.2    Cordero, J.A.3    Peraire, C.4    Obach, R.5    Vallès, J.6
  • 2
    • 69749100391 scopus 로고    scopus 로고
    • ENETS consensus guidelines for the standards of care in neuroendocrine tumors: Follow-up and documentation
    • Arnold, R., Chen, Y. J., Costa, F., Falconi, M., Gross, D., Grossman, A. B., et al. (2009). ENETS consensus guidelines for the standards of care in neuroendocrine tumors: Follow-up and documentation. Neuroendocrinology, 90(2), 227-233.
    • (2009) Neuroendocrinology , vol.90 , Issue.2 , pp. 227-233
    • Arnold, R.1    Chen, Y.J.2    Costa, F.3    Falconi, M.4    Gross, D.5    Grossman, A.B.6
  • 3
    • 21044441388 scopus 로고    scopus 로고
    • Long-acting octreotide and prolonged-release lanreotide formulations have different pharmacokinetic profiles
    • Astruc, B., Marbach, P., Bouterfa, H., Denot, C., Safari, M., Vitaliti, A., et al. (2005). Long-acting octreotide and prolonged-release lanreotide formulations have different pharmacokinetic profiles. Journal of Clinical Pharmacology, 45(7), 836-844.
    • (2005) Journal of Clinical Pharmacology , vol.45 , Issue.7 , pp. 836-844
    • Astruc, B.1    Marbach, P.2    Bouterfa, H.3    Denot, C.4    Safari, M.5    Vitaliti, A.6
  • 6
    • 15944427116 scopus 로고    scopus 로고
    • The antitumoral effects of somatostatin analog therapy in acromegaly
    • Bevan, J. S. (2005). The antitumoral effects of somatostatin analog therapy in acromegaly. Journal of Clinical Endocrinology and Metabolism, 90(3), 1856-1863.
    • (2005) Journal of Clinical Endocrinology and Metabolism , vol.90 , Issue.3 , pp. 1856-1863
    • Bevan, J.S.1
  • 7
    • 9844226192 scopus 로고    scopus 로고
    • Somatostatin receptor imaging in somatotroph and non functioning pituitary adenomas: Correlation with hormonal and visual responses to octreotide
    • (Oxford)
    • Borson-Chazot, F., Houzard, C., Ajzenberg, C., Nocaudie, M., Duet, M., Mundler, O., et al. (1997). Somatostatin receptor imaging in somatotroph and non functioning pituitary adenomas: Correlation with hormonal and visual responses to octreotide. Clinical Endocrinology (Oxford), 47(5), 589-598.
    • (1997) Clinical Endocrinology , vol.47 , Issue.5 , pp. 589-598
    • Borson-Chazot, F.1    Houzard, C.2    Ajzenberg, C.3    Nocaudie, M.4    Duet, M.5    Mundler, O.6
  • 8
    • 58149383820 scopus 로고    scopus 로고
    • Treatment of pituitary-dependent Cushing's disease with the multireceptor ligand somatostatin analog pasireotide (SOM230): A multicenter, phase II trial
    • Boscaro, M., Ludlam, W. H., Atkinson, B., Glusman, J. E., Petersenn, S., Reincke, M., et al. (2009). Treatment of pituitary-dependent Cushing's disease with the multireceptor ligand somatostatin analog pasireotide (SOM230): A multicenter, phase II trial. Journal of Clinical Endocrinology and Metabolism, 94(1), 115-122.
    • (2009) Journal of Clinical Endocrinology and Metabolism , vol.94 , Issue.1 , pp. 115-122
    • Boscaro, M.1    Ludlam, W.H.2    Atkinson, B.3    Glusman, J.E.4    Petersenn, S.5    Reincke, M.6
  • 9
    • 17844372727 scopus 로고    scopus 로고
    • Efficacy of the long-acting octreotide formulation (octreotide-LAR) in patients with thyrothropin-secreting pituitary adenomas
    • Caron, P., Arlot, S., Bauters, C., Chanson, P., Kuhn, J. M., Pugeat, M., et al. (2001). Efficacy of the long-acting octreotide formulation (octreotide-LAR) in patients with thyrothropin-secreting pituitary adenomas. Journal of Clinical Endocrinology and Metabolism, 86(6), 2849-285.
    • (2001) Journal of Clinical Endocrinology and Metabolism , vol.86 , Issue.6 , pp. 2849-3285
    • Caron, P.1    Arlot, S.2    Bauters, C.3    Chanson, P.4    Kuhn, J.M.5    Pugeat, M.6
  • 10
    • 0027376928 scopus 로고
    • Octreotide therapy for thyroid-stimulating hormone-secreting pituitary adenomas: A follow-up of 52 patients
    • Chanson, P., Weintraub, B. D., & Harris, A. G. (1993). Octreotide therapy for thyroid-stimulating hormone-secreting pituitary adenomas: A follow-up of 52 patients. Annals of Internal Medicine, 119(3), 236-240.
    • (1993) Annals of Internal Medicine , vol.119 , Issue.3 , pp. 236-240
    • Chanson, P.1    Weintraub, B.D.2    Harris, A.G.3
  • 11
    • 70349900717 scopus 로고    scopus 로고
    • Effects of initial therapy for five years with somatostatin analogs for acromegaly on growth hormone and insulin-like growth factor-I levels, tumor shrinkage, and cardiovascular disease: A prospective study
    • Colao, A., Auriemma, R. S., Galdiero, M., Lombardi, G., & Pivonello, R. (2009b). Effects of initial therapy for five years with somatostatin analogs for acromegaly on growth hormone and insulin-like growth factor-I levels, tumor shrinkage, and cardiovascular disease: A prospective study. Journal of Clinical Endocrinology and Metabolism, 94(10), 3746-56.
    • (2009) Journal of Clinical Endocrinology and Metabolism , vol.94 , Issue.10 , pp. 3746-3756
    • Colao, A.1    Auriemma, R.S.2    Galdiero, M.3    Lombardi, G.4    Pivonello, R.5
  • 12
    • 67650317928 scopus 로고    scopus 로고
    • Significant tumour shrinkage after 12 months of lanreotide Autogel-120mg treatment given first-line in acromegaly
    • Colao, A., Auriemma, R. S., Rebora, A., Galdiero, M., Resmini, E., Minuto, F., et al. (2009a). Significant tumour shrinkage after 12 months of lanreotide Autogel-120mg treatment given first-line in acromegaly. Clinical Endocrinology (Oxford), 71(2), 237-45.
    • (2009) Clinical Endocrinology (Oxford) , vol.71 , Issue.2 , pp. 237-245
    • Colao, A.1    Auriemma, R.S.2    Rebora, A.3    Galdiero, M.4    Resmini, E.5    Minuto, F.6
  • 14
    • 0035040518 scopus 로고    scopus 로고
    • Is the acromegalic cardiomyopathy reversible? Effect of 5-year normalization of growth hormone and insulin-like growth factor I levels on cardiac performance
    • Colao, A., Cuocolo, A., Marzullo, P., Nicolai, E., Ferone, D., Della Morte, A. M., et al. (2001). Is the acromegalic cardiomyopathy reversible? Effect of 5-year normalization of growth hormone and insulin-like growth factor I levels on cardiac performance. Journal of Clinical Endocrinology and Metabolism, 86(4), 1551-1557.
    • (2001) Journal of Clinical Endocrinology and Metabolism , vol.86 , Issue.4 , pp. 1551-1557
    • Colao, A.1    Cuocolo, A.2    Marzullo, P.3    Nicolai, E.4    Ferone, D.5    Della Morte, A.M.6
  • 16
    • 1442326975 scopus 로고    scopus 로고
    • Systemic complications of acromegaly: Epidemiology, pathogenesis, and management
    • Colao, A., Ferone, D., Marzullo, P., & Lombardi, G. (2004). Systemic complications of acromegaly: Epidemiology, pathogenesis, and management. Endocrine Reviews, 25(1), 102-152.
    • (2004) Endocrine Reviews , vol.25 , Issue.1 , pp. 102-152
    • Colao, A.1    Ferone, D.2    Marzullo, P.3    Lombardi, G.4
  • 17
    • 0037726793 scopus 로고    scopus 로고
    • Somatostatin analogs in treatment of non-growth hormone-secreting pituitary adenomas
    • Colao, A., Filippella, M., Di Somma, C., Manzi, S., Rota, F., Pivonello, R., et al. (2003). Somatostatin analogs in treatment of non-growth hormone-secreting pituitary adenomas. Endocrine, 20(3), 279-283.
    • (2003) Endocrine , vol.20 , Issue.3 , pp. 279-283
    • Colao, A.1    Filippella, M.2    Di Somma, C.3    Manzi, S.4    Rota, F.5    Pivonello, R.6
  • 18
    • 34249019847 scopus 로고    scopus 로고
    • Combined therapy of somatostatin analogues and dopamine agonists in the treatment of pituitary tumours
    • Colao, A., Filippella, M., Pivonello, R., Di Somma, C., Faggiano, A., & Lombardi, G. (2007b). Combined therapy of somatostatin analogues and dopamine agonists in the treatment of pituitary tumours. European Journal of Endocrinology, 156(Suppl. 1, 4), 57-63.
    • (2007) European Journal of Endocrinology , vol.156 , Issue.SUPPL. 14 , pp. 57-63
    • Colao, A.1    Filippella, M.2    Pivonello, R.3    Di Somma, C.4    Faggiano, A.5    Lombardi, G.6
  • 20
    • 0032585243 scopus 로고    scopus 로고
    • Growth hormone and prolactin excess
    • Colao, A., & Lombardi, G. (1998). Growth hormone and prolactin excess. Lancet, 352(9138), 1455-1461.
    • (1998) Lancet , vol.352 , Issue.9138 , pp. 1455-1461
    • Colao, A.1    Lombardi, G.2
  • 21
    • 33846952880 scopus 로고    scopus 로고
    • First-line therapy of acromegaly: A statement of the A.L.I.C.E. (acromegaly primary medical treatment learning and improvement with continuous medical education) study group
    • Colao, A., Martino, E., Cappabianca, P., Cozzi, R., Scanarini, M., & Ghigo, E., et al. (2006a). First-line therapy of acromegaly: A statement of the A.L.I.C.E. (acromegaly primary medical treatment learning and improvement with continuous medical education) study group. Journal of Endocrinological Investigation, 29(11), 1017-1020.
    • (2006) Journal of Endocrinological Investigation , vol.29 , Issue.11 , pp. 1017-1020
    • Colao, A.1    Martino, E.2    Cappabianca, P.3    Cozzi, R.4    Scanarini, M.5    Ghigo, E.6
  • 22
    • 33744954691 scopus 로고    scopus 로고
    • Predictors of tumor shrinkage after primary therapy with somatostatin analogs in acromegaly: A prospective study in 99 patients
    • Colao, A., Pivonello, R., Auriemma, R. S., Briganti, F., Galdiero, M., Tortora, F., et al. (2006b). Predictors of tumor shrinkage after primary therapy with somatostatin analogs in acromegaly: A prospective study in 99 patients. Journal of Clinical Endocrinology and Metabolism, 91(6), 2112-2118.
    • (2006) Journal of Clinical Endocrinology and Metabolism , vol.91 , Issue.6 , pp. 2112-2118
    • Colao, A.1    Pivonello, R.2    Auriemma, R.S.3    Briganti, F.4    Galdiero, M.5    Tortora, F.6
  • 25
  • 26
    • 33646022576 scopus 로고    scopus 로고
    • Primary treatment of acromegaly with octreotide LAR: A long-term (up to nine years) prospective study of its efficacy in the control of disease activity and tumor shrinkage
    • Cozzi, R., Montini, M., Attanasio, R., Albizzi, M., Lasio, G., Lodrini, S., et al. (2006). Primary treatment of acromegaly with octreotide LAR: A long-term (up to nine years) prospective study of its efficacy in the control of disease activity and tumor shrinkage. Journal of Clinical Endocrinology and Metabolism, 91(4), 1397-1403.
    • (2006) Journal of Clinical Endocrinology and Metabolism , vol.91 , Issue.4 , pp. 1397-1403
    • Cozzi, R.1    Montini, M.2    Attanasio, R.3    Albizzi, M.4    Lasio, G.5    Lodrini, S.6
  • 28
    • 0030667438 scopus 로고    scopus 로고
    • High-dose treatment with lanreotide of patients with advanced neuroendocrine gastrointestinal tumours: Clinical and biological effects
    • Eriksson, B., Renstrup, J., Imam, H., & Oberg, K. (1997). High-dose treatment with lanreotide of patients with advanced neuroendocrine gastrointestinal tumours: Clinical and biological effects. Annals of Oncology, 8(10), 1041-1044.
    • (1997) Annals of Oncology , vol.8 , Issue.10 , pp. 1041-1044
    • Eriksson, B.1    Renstrup, J.2    Imam, H.3    Oberg, K.4
  • 29
    • 54049152471 scopus 로고    scopus 로고
    • Effect of treatment with depot somatostatin analogue octreotide on primary hyperparathyroidism (PHP) in multiple endocrine neoplasia type 1 (MEN1) patients
    • (Oxford)
    • Faggiano, A., Tavares, L. B., Tauchmanova, L., Milone, F., Mansueto, G., Ramundo, V., et al. (2008). Effect of treatment with depot somatostatin analogue octreotide on primary hyperparathyroidism (PHP) in multiple endocrine neoplasia type 1 (MEN1) patients. Clinical Endocrinology (Oxford), 69(5), 756-762.
    • (2008) Clinical Endocrinology , vol.69 , Issue.5 , pp. 756-762
    • Faggiano, A.1    Tavares, L.B.2    Tauchmanova, L.3    Milone, F.4    Mansueto, G.5    Ramundo, V.6
  • 31
    • 33644664300 scopus 로고    scopus 로고
    • Somatostatin and dopamine receptor expression in lung carcinoma cells and effects of chimeric somatostatin-dopamine molecules on cell proliferation
    • Ferone, D., Arvigo, M., Semino, C., Jaquet, P., Saveanu, A., Taylor, J. E., et al. (2005). Somatostatin and dopamine receptor expression in lung carcinoma cells and effects of chimeric somatostatin-dopamine molecules on cell proliferation. American Journal of Physiology, Endocrinology and Metabolism, 289(6), E1044-E1050.
    • (2005) American Journal of Physiology, Endocrinology and Metabolism , vol.289 , Issue.6
    • Ferone, D.1    Arvigo, M.2    Semino, C.3    Jaquet, P.4    Saveanu, A.5    Taylor, J.E.6
  • 32
    • 67649304857 scopus 로고    scopus 로고
    • The clinical-molecular interface of somatostatin, dopamine and their receptors in pituitary pathophysiology
    • Epub
    • Ferone, D., Gatto, F., Arvigo, M., Resmini, E., Boschetti, M., Teti, C., et al. (2009). The clinical-molecular interface of somatostatin, dopamine and their receptors in pituitary pathophysiology. Journal of Molecular Endocrinology, 42(5), 361-370, Epub.
    • (2009) Journal of Molecular Endocrinology , vol.42 , Issue.5 , pp. 361-370
    • Ferone, D.1    Gatto, F.2    Arvigo, M.3    Resmini, E.4    Boschetti, M.5    Teti, C.6
  • 35
    • 0032470088 scopus 로고    scopus 로고
    • Thyrotropin secreting pituitary adenoma effectively treated with octreotide
    • Fukuda, T., Yokoyama, N., Tamai, M., Imaizumi, M., Kimura, H., Tominaga, T., et al. (1998). Thyrotropin secreting pituitary adenoma effectively treated with octreotide. Internal Medicine, 37(12), 1027-1030.
    • (1998) Internal Medicine , vol.37 , Issue.12 , pp. 1027-1030
    • Fukuda, T.1    Yokoyama, N.2    Tamai, M.3    Imaizumi, M.4    Kimura, H.5    Tominaga, T.6
  • 37
    • 0030911816 scopus 로고    scopus 로고
    • Octreotide long-acting release (LAR) A review of its pharmacological properties and therapeutic use in the management of acromegaly
    • Gillis, J. C., Noble, S., & Goa, K. L. (1997). Octreotide long-acting release (LAR). A review of its pharmacological properties and therapeutic use in the management of acromegaly. Drugs, 53(4), 681-699.
    • (1997) Drugs , vol.53 , Issue.4 , pp. 681-699
    • Gillis, J.C.1    Noble, S.2    Goa, K.L.3
  • 38
    • 68349141978 scopus 로고    scopus 로고
    • High-dose intramuscular octreotide in patients with acromegaly inadequately controlled on conventional somatostatin analogue therapy:Arandomised controlled trial
    • Giustina, A., Bonadonna, S., Bulgari, G., Colao, A., Cozzi, R., Cannavò, S., et al. (2009). High-dose intramuscular octreotide in patients with acromegaly inadequately controlled on conventional somatostatin analogue therapy:Arandomised controlled trial. European Journal of Endocrinology, 161(2), 331-338.
    • (2009) European Journal of Endocrinology , vol.161 , Issue.2 , pp. 331-338
    • Giustina, A.1    Bonadonna, S.2    Bulgari, G.3    Colao, A.4    Cozzi, R.5    Cannavò, S.6
  • 40
    • 4043060884 scopus 로고    scopus 로고
    • Somatostatin receptors in pituitary function, diagnosis and therapy
    • Hofland, L. J., & Lamberts, S. W. (2004). Somatostatin receptors in pituitary function, diagnosis and therapy. Frontiers of Hormone Research, 32, 235-52.
    • (2004) Frontiers of Hormone Research , vol.32 , pp. 235-252
    • Hofland, L.J.1    Lamberts, S.W.2
  • 41
    • 20244376493 scopus 로고    scopus 로고
    • The multi-ligand somatostatin analogue SOM230 inhibits ACTH secretion by cultured human corticotroph adenomas via somatostatin receptor type 5
    • Hofland, L. J., van der Hoek, J., Feelders, R., van Aken, M. O., van Koetsveld, P. M., Waaijers, M., et al. (2005). The multi-ligand somatostatin analogue SOM230 inhibits ACTH secretion by cultured human corticotroph adenomas via somatostatin receptor type 5. European Journal of Endocrinology, 152(4), 645-654.
    • (2005) European Journal of Endocrinology , vol.152 , Issue.4 , pp. 645-654
    • Hofland, L.J.1    van der Hoek, J.2    Feelders, R.3    van Aken, M.O.4    van Koetsveld, P.M.5    Waaijers, M.6
  • 42
    • 23244442834 scopus 로고    scopus 로고
    • Treatment of acromegaly with octreotide-LAR: Extensive experience in a Brazilian institution
    • Jallad, R. S., Musolino, N. R., Salgado, L. R., & Bronstein,. D. (2005). Treatment of acromegaly with octreotide-LAR: Extensive experience in a Brazilian institution. Clinical Endocrinology (Oxford), 63(2), 168-175.
    • (2005) Clinical Endocrinology (Oxford) , vol.63 , Issue.2 , pp. 168-175
    • Jallad, R.S.1    Musolino, N.R.2    Salgado, L.R.3    Bronstein, D.4
  • 43
    • 2942675021 scopus 로고    scopus 로고
    • The diagnosis and medical management of advanced neuroendocrine tumors
    • Kaltsas, G. A., Besser, G. M., & Grossman, A. B. (2004). The diagnosis and medical management of advanced neuroendocrine tumors. Endocrine Reviews, 25(3), 458-511.
    • (2004) Endocrine Reviews , vol.25 , Issue.3 , pp. 458-511
    • Kaltsas, G.A.1    Besser, G.M.2    Grossman, A.B.3
  • 45
    • 50249160709 scopus 로고    scopus 로고
    • Differential cytotoxicity of novel somatostatin and dopamine chimeric compounds on bronchopulmonary and small intestinal neuroendocrine tumor cell lines
    • Kidd, M., Drozdov, I., Joseph, R., Pfragner, R., Culler, M., & Modlin, I. (2008). Differential cytotoxicity of novel somatostatin and dopamine chimeric compounds on bronchopulmonary and small intestinal neuroendocrine tumor cell lines. Cancer, 113(4), 690-700.
    • (2008) Cancer , vol.113 , Issue.4 , pp. 690-700
    • Kidd, M.1    Drozdov, I.2    Joseph, R.3    Pfragner, R.4    Culler, M.5    Modlin, I.6
  • 46
    • 34547692987 scopus 로고    scopus 로고
    • A comparison of the effects of gastrin, somatostatin and dopamine receptor ligands on rat gastric enterochromaffin-like cell secretion and proliferation
    • Kidd, M., Modlin, I. M., Black, J. W., Boyce, M., & Culler, M. (2007). A comparison of the effects of gastrin, somatostatin and dopamine receptor ligands on rat gastric enterochromaffin-like cell secretion and proliferation. Regulatory Peptides, 143(1-3), 109-117.
    • (2007) Regulatory Peptides , vol.143 , Issue.1-3 , pp. 109-117
    • Kidd, M.1    Modlin, I.M.2    Black, J.W.3    Boyce, M.4    Culler, M.5
  • 47
    • 17744377962 scopus 로고    scopus 로고
    • Evaluation of the treatment of thyrothropin-secreting pituitary adenomas with a slow release formulation of the somatostatin analog lanreotide
    • Kuhn, J. M.,Arlot, S., Lefebvre,H., Caron, P., Cortell-Rudelli, C., Archambaud, F., et al. (2000). Evaluation of the treatment of thyrothropin-secreting pituitary adenomas with a slow release formulation of the somatostatin analog lanreotide. Journal of Clinical Endocrinology and Metabolism, 85(4), 1487-149.
    • (2000) Journal of Clinical Endocrinology and Metabolism , vol.85 , Issue.4 , pp. 1487-2149
    • Kuhn, J.M.1    Arlot, S.2    Lefebvre, H.3    Caron, P.4    Cortell-Rudelli, C.5    Archambaud, F.6
  • 49
    • 0028788593 scopus 로고
    • Imaging and medical management of clinically nonfunctioning pituitary tumours
    • Lamberts, S. W.J., de Herder, W. W., van der Lely, A. J., & Hofland, L. J. (1995). Imaging and medical management of clinically nonfunctioning pituitary tumours. Endocrinologist, 5, 448-451.
    • (1995) Endocrinologist , vol.5 , pp. 448-451
    • Lamberts, S.W.J.1    de Herder, W.W.2    van der Lely, A.J.3    Hofland, L.J.4
  • 51
    • 34249011944 scopus 로고
    • Is there a real medical treatment for the 'non-secreting' pituitary adenomas? (abstract)
    • Liuzzi, A., Dallabonzana, D., & Oppizzi, G. (1991). Is there a real medical treatment for the 'non-secreting' pituitary adenomas? (abstract). Journal of Endocrinological Investigation, 14(Suppl. 1), 18.
    • (1991) Journal of Endocrinological Investigation , vol.14 , Issue.SUPPL. 1 , pp. 18
    • Liuzzi, A.1    Dallabonzana, D.2    Oppizzi, G.3
  • 52
    • 84884491303 scopus 로고    scopus 로고
    • Effects of lanreotide SR and Autogel on tumor mass in patients with acromegaly: A systematic review
    • [Epub ahead of print]
    • Mazziotti, G., & Giustina, A. (2009). Effects of lanreotide SR and Autogel on tumor mass in patients with acromegaly: A systematic review. Pituitary. February 3 [Epub ahead of print].
    • (2009) Pituitary. February 3.
    • Mazziotti, G.1    Giustina, A.2
  • 53
    • 70449366466 scopus 로고    scopus 로고
    • Acromegaly pathogenesis and treatment
    • Melmed, S. (2009). Acromegaly pathogenesis and treatment. The Journal of Clinical Investigation, 119(11), 3189-3202.
    • (2009) The Journal of Clinical Investigation , vol.119 , Issue.11 , pp. 3189-3202
    • Melmed, S.1
  • 55
    • 34347380169 scopus 로고    scopus 로고
    • A prospective, multicentre study to investigate the efficacy, safety and tolerability of octreotide LAR (long-acting repeatable octreotide) in the primary therapy of patients with acromegaly
    • Mercado, M., Borges, F., Bouterfa, H., Chang, T. C., Chervin, A., Farrall, A. J., et al. (2007). A prospective, multicentre study to investigate the efficacy, safety and tolerability of octreotide LAR (long-acting repeatable octreotide) in the primary therapy of patients with acromegaly. Clinical Endocrinology (Oxford), 66(6), 859-868.
    • (2007) Clinical Endocrinology (Oxford) , vol.66 , Issue.6 , pp. 859-868
    • Mercado, M.1    Borges, F.2    Bouterfa, H.3    Chang, T.C.4    Chervin, A.5    Farrall, A.J.6
  • 56
    • 0027771501 scopus 로고
    • Effects of a chronic treatment with octreotide in patients with functionless pituitary adenomas
    • Merola, B., Colao, A., Ferone, D., Selleri, A., Di Sarno, A., Marzullo, P., et al. (1993). Effects of a chronic treatment with octreotide in patients with functionless pituitary adenomas. Hormone Research, 40(4), 149-155.
    • (1993) Hormone Research , vol.40 , Issue.4 , pp. 149-155
    • Merola, B.1    Colao, A.2    Ferone, D.3    Selleri, A.4    Di Sarno, A.5    Marzullo, P.6
  • 58
    • 49249113074 scopus 로고    scopus 로고
    • A critical analysis of clinically available somatostatin analog formulations for therapy of acromegaly
    • Murray, R. D., & Melmed, S. (2008). A critical analysis of clinically available somatostatin analog formulations for therapy of acromegaly. Journal of Clinical Endocrinology and Metabolism, 93(8), 2957-2968.
    • (2008) Journal of Clinical Endocrinology and Metabolism , vol.93 , Issue.8 , pp. 2957-2968
    • Murray, R.D.1    Melmed, S.2
  • 59
    • 29244462313 scopus 로고    scopus 로고
    • Evaluation and treatment of Cushing's syndrome
    • Nieman, L. K., & Ilias, I. (2005). Evaluation and treatment of Cushing's syndrome. American Journal of Medicine, 118(12), 1340-1346.
    • (2005) American Journal of Medicine , vol.118 , Issue.12 , pp. 1340-1346
    • Nieman, L.K.1    Ilias, I.2
  • 60
    • 68149168844 scopus 로고    scopus 로고
    • Somatostatin analog octreotide LAR in gastro-entero-pancreatic tumors
    • Oberg, K. (2009). Somatostatin analog octreotide LAR in gastro-entero-pancreatic tumors. Expert Reviews Anticancer Therapy, 9(5), 557-566.
    • (2009) Expert Reviews Anticancer Therapy , vol.9 , Issue.5 , pp. 557-566
    • Oberg, K.1
  • 61
    • 34547756475 scopus 로고    scopus 로고
    • Somatostatin receptor subtypes in human non-functioning neuroendocrine tumors and effects of somatostatin analogue SOM230 on cell proliferation in cell line NCI-H727
    • Ono, K., Suzuki, T., Miki, Y., Taniyama, Y., Nakamura, Y., Noda, Y., et al. (2007). Somatostatin receptor subtypes in human non-functioning neuroendocrine tumors and effects of somatostatin analogue SOM230 on cell proliferation in cell line NCI-H727. Anticancer Research, 27(4B), 2231-2239.
    • (2007) Anticancer Research , vol.27 , Issue.4 B , pp. 2231-2239
    • Ono, K.1    Suzuki, T.2    Miki, Y.3    Taniyama, Y.4    Nakamura, Y.5    Noda, Y.6
  • 62
    • 45749096710 scopus 로고    scopus 로고
    • Effects of somatostatin analog SOM230 on cell proliferation, apoptosis, and catecholamine levels in cultured pheochromocytoma cells
    • Pasquali, D., Rossi, V., Conzo, G., Pannone, G., Bufo, P., De Bellis, A., et al. (2008). Effects of somatostatin analog SOM230 on cell proliferation, apoptosis, and catecholamine levels in cultured pheochromocytoma cells. Journal of Molecular Endocrinology, 40(6), 263-271.
    • (2008) Journal of Molecular Endocrinology , vol.40 , Issue.6 , pp. 263-271
    • Pasquali, D.1    Rossi, V.2    Conzo, G.3    Pannone, G.4    Bufo, P.5    De Bellis, A.6
  • 64
    • 1942440916 scopus 로고    scopus 로고
    • Dopamine receptor expression and function in clinically nonfunctioning pituitary tumors: Comparison with the effectiveness of cabergoline treatment
    • Pivonello, R., Matrone, C., Filippella, M., Cavallo, L. M., Di Somma, C., Cappabianca, P., et al. (2004). Dopamine receptor expression and function in clinically nonfunctioning pituitary tumors: Comparison with the effectiveness of cabergoline treatment. Journal of Clinical Endocrinology and Metabolism, 89(4), 1674-1683.
    • (2004) Journal of Clinical Endocrinology and Metabolism , vol.89 , Issue.4 , pp. 1674-1683
    • Pivonello, R.1    Matrone, C.2    Filippella, M.3    Cavallo, L.M.4    Di Somma, C.5    Cappabianca, P.6
  • 65
    • 0028135581 scopus 로고
    • Preoperative octreotide treatment of growth hormone-secreting and clinically nonfunctioning pituitary macroadenomas: Effect on tumor volume and lack of correlation with immunohistochemistry and somatostatin receptor scintigraphy
    • Plöckinger, U., Reichel, M., Fett, U., Saeger, W., & Quabbe, H. J. (1994). Preoperative octreotide treatment of growth hormone-secreting and clinically nonfunctioning pituitary macroadenomas: Effect on tumor volume and lack of correlation with immunohistochemistry and somatostatin receptor scintigraphy. Journal of Clinical Endocrinology and Metabolism, 79(5), 1416-1423.
    • (1994) Journal of Clinical Endocrinology and Metabolism , vol.79 , Issue.5 , pp. 1416-1423
    • Plöckinger, U.1    Reichel, M.2    Fett, U.3    Saeger, W.4    Quabbe, H.J.5
  • 66
    • 0023118350 scopus 로고
    • Secretion of somatostatin and its physiologic function
    • Reichlin, S. (1987). Secretion of somatostatin and its physiologic function. Journal of Laboratory and Clinical Medicine, 109(3), 320-326.
    • (1987) Journal of Laboratory and Clinical Medicine , vol.109 , Issue.3 , pp. 320-326
    • Reichlin, S.1
  • 67
    • 70350442637 scopus 로고    scopus 로고
    • Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: A report from the PROMID study group
    • Rinke, A., Müller, H. H., Schade-Brittinger, C., Klose, K. J., Barth, P., Wied, M., et al. (2009). Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: A report from the PROMID study group. Journal of Clinical Oncology, 27(28), 4635-4636.
    • (2009) Journal of Clinical Oncology , vol.27 , Issue.28 , pp. 4635-4636
    • Rinke, A.1    Müller, H.H.2    Schade-Brittinger, C.3    Klose, K.J.4    Barth, P.5    Wied, M.6
  • 68
    • 0034616021 scopus 로고    scopus 로고
    • Receptors for dopamine and somatostatin: Formation of hetero-oligomers with enhanced functional activity
    • Rocheville, M., Lange, D. C., Kumar, U., Patel, S. C., Patel, R. C., & Patel, Y. C. (2000). Receptors for dopamine and somatostatin: Formation of hetero-oligomers with enhanced functional activity. Science, 288(5463), 154-157.
    • (2000) Science , vol.288 , Issue.5463 , pp. 154-157
    • Rocheville, M.1    Lange, D.C.2    Kumar, U.3    Patel, S.C.4    Patel, R.C.5    Patel, Y.C.6
  • 69
    • 68649087646 scopus 로고    scopus 로고
    • Therapeutic options in the management of acromegaly: Focus on lanreotide autogel
    • Roelfsema, F., Biermasz, N. R., Pereira, A. M., & Romijn, J. A. (2008). Therapeutic options in the management of acromegaly: Focus on lanreotide autogel. Biologics, 2(3), 463-479.
    • (2008) Biologics , vol.2 , Issue.3 , pp. 463-479
    • Roelfsema, F.1    Biermasz, N.R.2    Pereira, A.M.3    Romijn, J.A.4
  • 70
    • 43549111835 scopus 로고    scopus 로고
    • Pasireotide (SOM230): Development, mechanism of action and potential applications
    • Schmid, H. A. (2008). Pasireotide (SOM230): Development, mechanism of action and potential applications. Molecular and Cellular Endocrinology, 286(1-2), 69-74.
    • (2008) Molecular and Cellular Endocrinology , vol.286 , Issue.1-2 , pp. 69-74
    • Schmid, H.A.1
  • 72
    • 67349158003 scopus 로고    scopus 로고
    • Expression of somatostatin and dopamine 2 receptors in neuroendocrine tumours and the potential role for new biotherapies
    • Srirajaskanthan, R., Watkins, J., Marelli, L., Khan, K., & Caplin, M. E. (2009). Expression of somatostatin and dopamine 2 receptors in neuroendocrine tumours and the potential role for new biotherapies. Neuroendocrinology, 89 (3), 308-314.
    • (2009) Neuroendocrinology , vol.89 , Issue.3 , pp. 308-314
    • Srirajaskanthan, R.1    Watkins, J.2    Marelli, L.3    Khan, K.4    Caplin, M.E.5
  • 73
    • 0026424156 scopus 로고
    • Analgesic effect on headaches of octreotide, a somatostatin analogue, in a case of non-functioning pituitary adenoma
    • Turpin, G., Foubert, L., Noel-Wekstein, S., Kujas, M., & De Gennes, J. L. (1991). Analgesic effect on headaches of octreotide, a somatostatin analogue, in a case of non-functioning pituitary adenoma. Presse Medicale, 20(43), 2219-2220.
    • (1991) Presse Medicale , vol.20 , Issue.43 , pp. 2219-2220
    • Turpin, G.1    Foubert, L.2    Noel-Wekstein, S.3    Kujas, M.4    De Gennes, J.L.5
  • 74
    • 0030820137 scopus 로고    scopus 로고
    • A prospective multicenter trial of octreotide in 24 patients with visual defects caused by nonfunctioning and gonadotropin-secreting pituitary adenomas: French multicenter octreotide study group
    • Warnet, A., Harris, A. G., Renard, E., Martin, D., James-Deidier, A., & Chaumet-Riffaud, P. (1997). A prospective multicenter trial of octreotide in 24 patients with visual defects caused by nonfunctioning and gonadotropin-secreting pituitary adenomas: French multicenter octreotide study group. Neurosurgery, 41(4), 786-797.
    • (1997) Neurosurgery , vol.41 , Issue.4 , pp. 786-797
    • Warnet, A.1    Harris, A.G.2    Renard, E.3    Martin, D.4    James-Deidier, A.5    Chaumet-Riffaud, P.6
  • 76
    • 46449110634 scopus 로고    scopus 로고
    • One hundred years after "carcinoid": Epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States
    • Yao, J. C., Hassan, M., Phan, A., Dagohoy, C., Leary, C., Mares, J. E., et al. (2008). One hundred years after "carcinoid": Epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. Journal of Clinical Oncology, 26(18), 3063-3072.
    • (2008) Journal of Clinical Oncology , vol.26 , Issue.18 , pp. 3063-3072
    • Yao, J.C.1    Hassan, M.2    Phan, A.3    Dagohoy, C.4    Leary, C.5    Mares, J.E.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.